DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Ahmed N, Brawley VS, Hegde M. et al.
Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigenreceptor-modified T cells for the immunotherapy of HER2-positive sarcoma.

J Clin Oncol 2015;
33: 1688-1696

Download Bibliographical Data

Search in:
Access:
Access: